Chemify

Digital chemistry platform uniting AI, robotics, and 'chemputation' to design and synthesize small molecules from code.

Chemify, founded in 2022 as a spin-out of the University of Glasgow and headquartered in Glasgow, United Kingdom, combines AI, robotics, and its 'chemputation' approach to design small molecules directly from code and automate their synthesis, targeting drug discovery and advanced materials. The company raised an oversubscribed Series B of more than $50M. Atlas found no vendor-held security certifications documented on its site.

Headquarters
Glasgow, United Kingdom
Founded
2022
Deployment options
cloud
Website
https://chemify.io
LinkedIn
https://www.linkedin.com/company/chemify-limited

Categories

AI Use Cases

  • Hit Identification & Lead Optimization

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents Chemify across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, Large Pharma, Drug Discovery, R&D Leadership

Solution Scope — Documented

Molecular Generation

Company Viability — Partially documented

Series B, Founded 2022

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which molecule classes and reaction types does the chemputation platform reliably synthesize?
  • How is synthesis reproducibility validated across runs and sites?
  • How is IP ownership handled for molecules designed and made on the platform?
  • What partnership and engagement models are available for our programs?